IABR News
Supported By
Prof. Cristina Davis is a Professor of Mechanical and Aerospace Engineering and Associate Dean for Research in the College of Engineering at the University of California, Davis (Davis, CA). Her research group focuses on novel breath biomarker discovery, and creating miniature analytical sensor systems for mobile chemical detection platforms. She earned her BS degree (1994) at Duke University with a double major in mathematics and biology. She went completed her PhD (1999) in biomedical engineering at the University of Virginia, and completed a postdoctoral fellowship at The Johns Hopkins University (2001). She worked in industry in Switzerland (2001-2002) and went on to become a Principal Member of the Technical Staff and the founding Group Leader of Bioengineering at The Charles Stark Draper Laboratory (Cambridge, MA; 2002-2005). Having spent almost a half-decade in industry, she returned to academics in November 2005. She is a Fellow of the American Institute for Medical and Biological Engineering (AIMBE), the American Association for the Advancement of Science (AAAS) and National Academy of Inventors (NAI). She is the incoming chair-elect of the International Association of Breath Research (IABR).
Dr. Jens Herbig is currently the Chief Technology Officer (CTO) of IONICON Analytik. The Austria based company is the leading manufacturer of PTR-MS trace gas analysers and provides solutions for real-time monitoring of volatile organic compounds. After his PhD in Physics, he joined the spin-off IONIMED in 2006 to advance PTR-MS applications in medicine and biotechnology. When in 2013 the two companies merged, he was promoted CTO of IONICON with responsibilities including the development of new application areas. Soon thereafter IONICON made the first step into an emerging market, AMC monitoring for the semiconductor industry that should soon become the most rapidly growing business for PTR technology for the next years. With his growing team Dr. Herbig translated a complex, high-end scientific analyser to an automated industrial monitoring system.
Website: https://ultrapuremicroevents.com/personnel/jens-herbig/
Research leader at the Department of Medical Sciences; Respiratory, Allergy and Sleep Research, Uppsala University, Sweden. After a predoctoral position at the Anesthesia Research Laboratory, University of California, USA, she obtained a PhD position at the Uppsala University in 1991, where she defended her thesis “Bronchial reactivity in rabbits and humans -modulation with nitric oxide and hypertonic saline” in 1994 and became professor in 2006.
Her research field is respiratory physiology, with a special interest in the production of nitric oxide. After an early stage spent to perform in-vitro studies and in-vivo experiments in rabbits, pigs and horses, in the last 20 years her research has focused on human lung diseases such as asthma and chronic obstructive pulmonary disease, both in Sweden and in Nepal, and more recently on sports medicine (airway epithelium). Since the discovery of the flow dependency of exhaled nitric oxide breath concentration by her research team, she has served on ATS and ERS task forces and is now serving on five ERS taskforces for exhaled nitric oxide.
Website: https://biography.omicsonline.org/sweden/uppsala-biomedical-centre/marieann-hgman-465361
Jane obtained her PhD from Yale University in Chemical Engineering doing research that emphasized links between analytical chemistry and microbiological processes. Prior to this, she ran a consulting company that focused on conducting environmental assessments and remediation of contaminated sites. The consulting work built out from her technical MBA and undergraduate Engineering degree from Rensselaer Polytechnic Institute. Jane has authored over 60 papers and is the Canadian Research Chair of Breath Science and Technologies at the University of British Columbia. Her team specializes in the discovery and clinical validation of biomarkers of infectious diseases.
Dr. Anil Modak currently serves on the Scientific Advisory Board of Owlstone Medical Cambridge, England and the former Associate Director of Medical Products R&D at Cambridge Isotope Laboratories Inc. in Teksbury, MA, has been involved in the design, research and development of novel non invasive breath tests for personalized medicine using stable isotope substrates for the diagnosis of disease states and evaluation of enzyme activity. He is the author of several patents, publications and has made several presentations around the world at medical/scientific conferences. He has reviewed several papers for reputed journals and authored three book chapters. He serves on the Editorial board of the Journal of Breath Research, Insights in Medical science, Journal of Pharmacogenomics & Pharmacoproteomics and International Journal of Clinical Pharmacology & Toxicology.
His previous experience includes working for Ribozyme Pharmaceuticals in Boulder, CO and Monsanto in St Louis, MO. His postdoctoral research was conducted at the University of Iowa and Kings College London. His research interests are mainly related to design and develop novel, non invasive, phenotype breath tests using stable isotope substrates for identifying responders/non responders for various drugs metabolized by specific polymorphic P450 CYP enzymes to enable physicians personalize medication for patients.
Website: https://www.linkedin.com/in/anil-modak-phd-244761118
The event will start at:
BREATH SUMMIT 2022
12|15 June 2022 - Pisa, Italy
CNR Auditorium CNR Research Area
Via G.Moruzzi, 1 - Pisa - Italy
Privacy Policy - Info Covid - Abstracts
Downloadable Contents
